Thyrocare Technologies Ltd (BOM:539871)

Q4 2026 Thyrocare Technologies Ltd Earnings Call Transcript

May 11, 2026 / 03:30 AM GMT

Release Date Price: ₹475.6 (-0.96%)

Transcript

Key Points

Positve

Thyrocare Technologies Ltd (BOM:539871) reported a strong revenue growth of 21% year-on-year for FY26, driven by its core pathology business.
The company expanded its franchise network to 10,800 active franchisees, marking its highest level ever, which contributed to an 18% year-on-year growth in the franchisee business.
Thyrocare's diagnostic portfolio saw significant growth, with the Jaanch segment growing by 66% year-on-year, indicating a shift towards more specialized disease-specific testing.
The company achieved a Six Sigma level of performance in quality metrics, with complaints reducing to 3.06 per million tests.
Thyrocare's international operations in Tanzania, though small, grew by 75% year-on-year, indicating successful international expansion efforts.

Negative

The partnership business experienced a one-off dip in Q4 FY26, with growth at 23% compared to previous quarters, due to normalization of pricing in the insurance segment and reduced scale of camps.
Despite the growth in test volumes, the Tanzania operations have not yet reached break-even, contributing minimal losses to the overall financials.
The company faces potential challenges with raw material price increases due to global supply chain issues, which could impact margins.
Thyrocare's radiology segment saw a temporary impact on growth due to strategic consolidation of centers, affecting overall financial performance.
The specialty segment, including genomics, is still in its nascent stage, and significant revenue contributions are not expected until FY28 and beyond.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

THYO.NS - Thyrocare Technologies Ltd
Q4 2026 Thyrocare Technologies Ltd Earnings Call
May 12, 2026 / 03:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day, and welcome to the TyroCare Q4 FY26 Earnings Conference Call, hosted by TyroCare Technologies Limited.

As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing *, then zero on a touchstone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Preet Joshi from TyroCare.

Thank you, and over to you, sir.

--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.